Try it
Ophthalmology · Cornea: neurotrophic keratitis
Sample itemAfter a trigeminal neuralgia ablation, a patient develops a painless, non-healing central epithelial defect with reduced corneal sensation. Which agent is approved for stage 2 and 3 disease?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Cenegermin (recombinant human nerve growth factor)
Neurotrophic keratitis is due to loss of trigeminal innervation and trophic factors, so it is painless. Cenegermin eye drops promote epithelial healing, and measures like lubricants, bandage lens, tarsorrhaphy and amniotic membrane help. Steroids worsen melting.
Option by option
A. Topical steroid
Steroids impair healing.
B. Cenegermin (recombinant human nerve growth factor) (correct)
Correct. Cenegermin is approved for neurotrophic keratitis.
C. Topical cyclosporine only
Cyclosporine alone does not address nerve loss.
D. Natamycin
Natamycin treats fungal infections.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Ophthalmology questions
- Cornea: neurotrophic keratitisAfter a trigeminal neurectomy, a patient develops a persistent central epithelial defect…
- GlaucomaWhich topical glaucoma medicine lowers intraocular pressure mainly by increasing uveoscl…
- Ocular oncologyA 2-year-old child has a white pupillary reflex (leukocoria). The gene commonly involved…
- UveaA patient has a painful red eye with photophobia, ciliary congestion, a small irregular…